Virus-inactivated factor Xa preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 681, 514 12, 514834, 530381, 530382, 530829, 530830, A61K 3836, A61K 3516, C07K 14745, C07K 116

Patent

active

055939686

ABSTRACT:
A virus-inactivated Factor-Xa preparation with at least 100 units coagulation factor activity per mg protein is described, wherein this preparation is produced by activation of a corresponding starting material and subsequent treatment for the inactivation of infectious agents, particularly viruses. By incubation, the preparation obtained in this manner is transformed into a stable beta-Factor Xa preparation. In addition, the use of the present preparation for the treatment of hemophilia A inhibitor patients is disclosed.

REFERENCES:
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4495278 (1985-01-01), Thomas
patent: 4501731 (1985-02-01), Tishkoff et al.
patent: 4640834 (1987-02-01), Eibl et al.
patent: 4687664 (1987-08-01), Philapitsch et al.
patent: 5410022 (1995-04-01), Eibl et al.
Radcliffe et al., "Comparisions of the Molecular Forms of Activated Bovine Factor X", J. Bio. Chem., 248(19):6788-6795 (1973).
Radcliffe et al., "The Purification and Properties of Activated Factor X", J. Bio. Chem., 247(23):7735-7742 (1972).
Yue et al., "Isolation of the High Molecular Form of Bovine Factor X and Some of its Physical Properties", Biochimica et Biophysica Acta 490:350-362 (1977).
Novoa et al., "Improved Procedures for the Purification of Selected Vitamin K-Dependent Proteins", Preparative Biology, 6(5):307-338 (1976).
J. C. Giddings, "Molecular Genetics and Immunoanalysis in Blood Coagulation", 1988, pp. 46-52.
Jesty et al., "The Activation of Cleavage Sites in the Alternative Pathays and Characterization of the Cooh-Terminal Peptide*", The Journal of Biological Chemistry, vol. 250, No. 12, Jun. 1975, pp. 4497-4504.
Jesty et al., "The Mechanism of Activation of Factor X", The Journal of Biological Chemistry, vol. 249, No. 17, Sep. 1974, pp. 5614-5622.
Fujikawa et al., "Activation of Bovine Factor X (Stuart Factor): Conversion of Factor X.sub.a.alpha. to Factor X.sub.a.beta. ", Proc. Nat. Acad. Sci., vol. 72, No. 9, Sep. 1975, pp. 3359-3363.
Teng et al., "Production of Factor X and Factor Xa Variants with Thrombin, Acutin and by Autolysis", Thrombosis Research, vol. 22, No. 1/2, 1981, pp. 213-220.
Bajaj et al., "Simultaneous Purification of Bovine Prothrombin and Factor", The Journal of Biological Chem., vol. 248, No. 22, Apr. 1973, pp. 7729-7741.
Mertens et al., "Pathways in the Activation of Human Coagulation Factor X", J. Biochem. vol. 185, 1980, pp. 647-658.
Wolf et al., "Design of Constructs for the Expression of Biologically Recombinant Human Factors X and Xa", J. Bio. Chem., vol. 266, No. 21, Jul. 1991, pp. 13726-13730.
H. G. J. Brummelhuis, "Preparation of the Prothrombin Complex", Acad. Pres, 1980, pp. 117-128.
Miletich et al., "The Synthesis of Sulfated Dextran Beads for Isolation of Human Plasma Coagulation Factors II, IX, and X.sup.1 ", Analytical Biochem., 105, 1980, pp. 304-310.
Kisiel et al. "Factor X Activating Enzyme from Russell's Viper Venom: Isolation & Characterization" Biochemistry 15(22) 4901-4906 1976.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Virus-inactivated factor Xa preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virus-inactivated factor Xa preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus-inactivated factor Xa preparation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1388201

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.